Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA — DARE-VVA1

Vulvar Atrophy Clinical Trial

Official title:
Phase 1/2 Study of Intravaginal Tamoxifen (DARE-VVA1): Randomized, Double-blind, Placebo-controlled Study of Safety, Pharmacokinetics and Pharmacodynamics in Postmenopausal Participants With Moderate to Sever Vulvar and Vaginal Atrophy

Status Completed

Clinical Trial Summary

The purpose of the study is to study the safety, PK and PD of Intravaginal Tamoxifen on postmenopausal women with vulvar vaginal atrophy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05378269
Study type	Interventional
Source	Daré Bioscience, Inc.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	November 22, 2021
Completion date	March 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04705883` - Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors	Phase 4
Completed	`NCT02937805` - Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes	N/A
Terminated	`NCT01753102` - Efficacy and Safety Of Spil's Estradiol Vaginal Tablet	Phase 3
Completed	`NCT04147689` - Evaluation of the Efficacy and Safety of Hyaluronic Acid Injection in Labia Majora for Volume Restoration	N/A
Recruiting	`NCT05890092` - Vulvar Disease in Nigeria Observational Study
Not yet recruiting	`NCT06333782` - Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora Augmentation	N/A
Completed	`NCT02966925` - Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness	N/A
Not yet recruiting	`NCT00453089` - VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women	Phase 1/Phase 2
Recruiting	`NCT04042766` - Laser Vaginal Treatment for GSM	N/A